BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 27320765)

  • 1. Anticoagulants in dermatology.
    Adya KA; Inamadar AC; Palit A
    Indian J Dermatol Venereol Leprol; 2016; 82(6):626-640. PubMed ID: 27320765
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The skin and hypercoagulable states.
    Thornsberry LA; LoSicco KI; English JC
    J Am Acad Dermatol; 2013 Sep; 69(3):450-62. PubMed ID: 23582572
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Survival of heparins, oral anticoagulants, and aspirin after the year 2010.
    Fareed J; Hoppensteadt DA; Fareed D; Demir M; Wahi R; Clarke M; Adiguzel C; Bick R
    Semin Thromb Hemost; 2008 Feb; 34(1):58-73. PubMed ID: 18393143
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Current status of the management of venous thromboembolism in Japan].
    Nakamura M
    Nihon Rinsho; 2014 Jul; 72(7):1298-302. PubMed ID: 25163325
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Changing trends in anti-coagulant therapies. Are heparins and oral anti-coagulants challenged?
    Fareed J; Iqbal O; Cunanan J; Demir M; Wahi R; Clarke M; Adiguzel C; Bick R
    Int Angiol; 2008 Jun; 27(3):176-92. PubMed ID: 18506123
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Current and emerging options in the management of venous thromboembolism.
    Jaffer AK; Brotman DJ; Michota F
    Cleve Clin J Med; 2005 Apr; 72 Suppl 1():S14-23. PubMed ID: 15853175
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anticoagulant therapy: basic principles, classic approaches and recent developments.
    Sinauridze EI; Panteleev MA; Ataullakhanov FI
    Blood Coagul Fibrinolysis; 2012 Sep; 23(6):482-93. PubMed ID: 22732252
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clearing the way: treating venous thromboembolism and deep vein thrombosis.
    Lambing A
    Adv Nurse Pract; 2005 Jun; 13(6):24-30; quiz 31. PubMed ID: 15984353
    [No Abstract]   [Full Text] [Related]  

  • 9. Emerging anticoagulants for the treatment of venous thromboembolism.
    Weitz JI
    Thromb Haemost; 2006 Sep; 96(3):274-84. PubMed ID: 16953267
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Deep vein thrombosis and anticoagulant therapy.
    Sullano MA; Ortiz EJ
    Nurs Clin North Am; 2001 Dec; 36(4):645-63, v. PubMed ID: 11726345
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The potential role of new oral anticoagulants in the prevention and treatment of thromboembolism.
    Mavrakanas T; Bounameaux H
    Pharmacol Ther; 2011 Apr; 130(1):46-58. PubMed ID: 21185864
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Old and new anticoagulant drugs: a minireview.
    Mannucci PM; Franchini M
    Ann Med; 2011 Mar; 43(2):116-23. PubMed ID: 21254900
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Indications for anticoagulants].
    Oger E; Mottier D
    Rev Prat; 1999 Oct; 49(15):1648-53. PubMed ID: 10581995
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Heparin-induced thrombocytopenia.
    Warkentin TE
    Dis Mon; 2005; 51(2-3):141-9. PubMed ID: 15900266
    [No Abstract]   [Full Text] [Related]  

  • 15. Treating patients with venous thromboembolism: initial strategies and long-term secondary prevention.
    Huisman MV; Bounameaux H
    Semin Vasc Med; 2005 Aug; 5(3):276-84. PubMed ID: 16123915
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Warfarin and heparin-induced skin necrosis and the purple toe syndrome: infrequent complications of anticoagulant treatment.
    Sallah S; Thomas DP; Roberts HR
    Thromb Haemost; 1997 Aug; 78(2):785-90. PubMed ID: 9268171
    [No Abstract]   [Full Text] [Related]  

  • 17. Transition to an oral anticoagulant in patients with heparin-induced thrombocytopenia.
    Bartholomew JR
    Chest; 2005 Feb; 127(2 Suppl):27S-34S. PubMed ID: 15706028
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The treatment of deep venous thrombosis, including the newer agents.
    Rectenwald JE; Wakefield TW
    Dis Mon; 2005; 51(2-3):104-11. PubMed ID: 15900261
    [No Abstract]   [Full Text] [Related]  

  • 19. Benefit-risk profile of non-vitamin K antagonist oral anticoagulants in the management of venous thromboembolism.
    Beyer-Westendorf J; Ageno W
    Thromb Haemost; 2015 Feb; 113(2):231-46. PubMed ID: 25319150
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fondaparinux versus direct thrombin inhibitor therapy for the management of heparin-induced thrombocytopenia (HIT)--bridging the River Coumarin.
    Warkentin TE
    Thromb Haemost; 2008 Jan; 99(1):2-3. PubMed ID: 18217128
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.